These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16820901)

  • 21. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
    Al-Hussaini M; Hirschowitz L; McCluggage WG
    Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors.
    Morozov A; Lee SJ; Zhang ZK; Cimica V; Zagzag D; Kalpana GV
    Clin Cancer Res; 2007 Aug; 13(16):4721-30. PubMed ID: 17699849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
    Craig E; Zhang ZK; Davies KP; Kalpana GV
    EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.
    Vries RG; Bezrookove V; Zuijderduijn LM; Kia SK; Houweling A; Oruetxebarria I; Raap AK; Verrijzer CP
    Genes Dev; 2005 Mar; 19(6):665-70. PubMed ID: 15769941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence for epidermal growth factor receptor amplification and overexpression in atypical teratoid/rhabdoid tumors.
    Jeibmann A; Buerger H; Frühwald M; Hasselblatt M
    Acta Neuropathol; 2006 Oct; 112(4):513-4. PubMed ID: 16896904
    [No Abstract]   [Full Text] [Related]  

  • 29. Multicentric atypical teratoid/rhabdoid tumors occurring in the eye and fourth ventricle of an infant: case report.
    Fujita M; Sato M; Nakamura M; Kudo K; Nagasaka T; Mizuno M; Amano E; Okamoto Y; Hotta Y; Hatano H; Nakahara N; Wakabayashi T; Yoshida J
    J Neurosurg; 2005 Apr; 102(3 Suppl):299-302. PubMed ID: 15881754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two single nucleotide polymorphisms of the hSNF5/INI1 gene.
    Mine N; Bando K; Utada Y; Nagai H; Araki T; Emi M
    J Hum Genet; 1999; 44(5):354-5. PubMed ID: 10496084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.
    Alarcon-Vargas D; Zhang Z; Agarwal B; Challagulla K; Mani S; Kalpana GV
    Oncogene; 2006 Feb; 25(5):722-34. PubMed ID: 16302003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo.
    Kuwahara Y; Hosoi H; Osone S; Kita M; Iehara T; Kuroda H; Sugimoto T
    Clin Cancer Res; 2004 Sep; 10(17):5940-8. PubMed ID: 15355927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A malignant rhabdoid tumor appearing simultaneously in the kidney and the brain of an infant: case report].
    Morizane A; Nakahara I; Takahashi JA; Ishikawa M; Kikuchi H
    No Shinkei Geka; 1997 Jul; 25(7):665-9. PubMed ID: 9218263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mutation of the SMARCB1 gene in a case of extrarenal malignant rhabdoid tumor.
    Koitabashi M; Kanazawa T; Tamura K; Tsukada S; Suzuki M; Morikawa A; Ogawa C; Hirado J
    Cancer Genet Cytogenet; 2008 Feb; 181(1):67-8. PubMed ID: 18262058
    [No Abstract]   [Full Text] [Related]  

  • 38. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
    Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
    Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric embryonal tumor of the cerebellum with rhabdoid cells and novel intracytoplasmic inclusions: distinction from atypical teratoid/rhabdoid tumor.
    Sasaki A; Kurihara H; Ishiuchi S; Hirato J; Saito N; Nakazato Y
    Acta Neuropathol; 2005 Jul; 110(1):69-76. PubMed ID: 15965700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient.
    Kuwahara Y; Iehara T; Ichise E; Katsumi Y; Ouchi K; Tsuchiya K; Miyachi M; Konishi E; Sasajima H; Nakamura S; Fumino S; Tajiri T; Johann PD; FrÜhwald MC; Yoshida T; Okuda T; Hosoi H
    Anticancer Res; 2020 Nov; 40(11):6159-6170. PubMed ID: 33109553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.